Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

NCT00769119 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

NCT01314716 ·Status: COMPLETED ·Phase: PHASE3

Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa

NCT03715322 ·Status: UNKNOWN ·Phase: PHASE3

Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

NCT00794586 ·Status: COMPLETED ·Phase: PHASE2

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

NCT02081963 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

NCT01313624 ·Status: COMPLETED ·Phase: PHASE3

Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

NCT02106832 ·Status: COMPLETED ·Phase: PHASE3

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

NCT00205647 ·Status: COMPLETED ·Phase: PHASE2

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

NCT02714283 ·Status: COMPLETED

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

NCT04596319 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

NCT06093191 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

NCT03449459 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

NCT00255983 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

NCT00930982 ·Status: COMPLETED ·Phase: PHASE2

Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study

NCT06229613 ·Status: COMPLETED

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

NCT04313023 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

NCT07198347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study With Phage for CF Subjects With Pseudomonas Lung Infection

NCT06998043 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

NCT01746095 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

NCT01315691 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

NCT02058407 ·Status: TERMINATED ·Phase: PHASE1

Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

NCT02632851 ·Status: COMPLETED

Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

NCT00391976 ·Status: COMPLETED ·Phase: PHASE3

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

NCT03460704 ·Status: TERMINATED ·Phase: PHASE3

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

NCT05986318 ·Status: RECRUITING ·Phase: PHASE2